Sun Life Financial Inc. · SLF · FY2026 Q2 · Calendar Q3 2026
Sun Life posts strong Q2 EPS growth as risks remain in dental and asset management
Sun Life's Q2 results support a constructive operating picture: earnings growth, Asia and U.S. momentum, asset-management flows, and strong capital were offset by identifiable execution and margin risks. The balance of evidence favors monitoring whether these growth drivers persist while dental restructuring and fee pressure are contained.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about SLF FY2026 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The latest call added stronger underlying EPS growth, continued Asia and U.S. momentum, new AI and health-solution initiatives, Bell integration, and further private-credit progress; management also emphasized Medicaid dental restructuring and fee pressure.
Guidance delta
Maintained; management's forward priorities remained focused on AI tools, health solutions, commercial dental expansion, Bell integration, and asset-management margin improvement.
Key takeaways
- Underlying EPS growth and near-20% underlying ROE support the operating momentum case.
- Asia sales, U.S. stop-loss, private-credit fundraising, and asset-management flows were highlighted as growth drivers.
- Capital remained strong, but Medicaid dental restructuring, active-equity outflows, and pricing pressure remain watch items.
Management priorities
- Roll out the agentic AI platform and AI-powered advisor concierge.
- Expand health solutions and commercial dental while exiting unprofitable Medicaid contracts.
- Integrate Bell and pursue asset-management growth and operating-margin improvement.
Follow SLF with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 22, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Argus Research | Buy | Buy | Maintain | Sep 3, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Aug 10, 2026 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 10, 2023 |
| CFRA | Hold | Hold | Maintain | May 12, 2020 |
| CIBC | Underperform | Neutral | Downgrade | Mar 14, 2019 |
| Scotiabank | Sector Perform | Sector Outperform | Downgrade | Feb 6, 2019 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Apr 5, 2018 |
| BMO Capital | Outperform | Market Perform | Upgrade | Feb 16, 2018 |
| Canaccord Genuity | Hold | Buy | Downgrade | Nov 17, 2016 |
| Jefferies | Hold | Hold | Maintain | Jul 27, 2016 |
| Macquarie | Neutral | Outperform | Downgrade | Nov 5, 2015 |
| Cormark Securities | Market Perform | Buy | Downgrade | Dec 19, 2012 |
| Barclays | Underweight | Underweight | Maintain | Nov 9, 2012 |
| Desjardins | Hold | Buy | Downgrade | Oct 11, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $81.44. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Argus Research | Analyst unavailable | $88 | $79.46 | +8.1% | Sep 3, 2026 |
| Argus Research | Kevin Heal | $81 | $74.52 | -0.5% | Jun 10, 2026 |
| Morgan Stanley | Analyst unavailable | $89 | $60.41 | +9.3% | Oct 7, 2025 |
| Capital One Financial | Tom MacKinnon | $92 | $60.9 | +13.0% | Nov 14, 2024 |
| Stifel Nicolaus | Mike Rizvanovic | $58.89 | $51.95 | -27.7% | Oct 4, 2021 |
| Barclays | John Aiken | $50.93 | $50.38 | -37.5% | Aug 5, 2021 |
Track every rating change on SLF the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationSun Life Financial Inc. operates as a global financial institution, delivering a wide range of insurance, wealth management, and asset accumulation services to both individual and corporate clients worldwide. Its offerings encompass diverse life insurance products, including term and whole life policies, in addition to personal health, dental, critical illness, long-term care, and disability coverage. The company also engages in reinsurance activities, provides investment advisory and portfolio management services, and administers mutual and segregated funds. Furthermore, it offers trust and banking solutions, along with real estate brokerage, appraisal, and merchant banking services. Its distribution network is extensive, utilizing direct sales representatives, various general agents (both managing and independent), financial intermediaries, broker-dealers, banking institutions, pension and benefits consultants, and other external marketing organizations. Founded in 1871, the firm's headquarters are located in Toronto, Canada.
Financial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| PUK Prudential plc | FY2026 Q2 · Calendar Q3 2026 | -40.9% | -0.5% | Prudential sustains growth and capital returns focus in H1 2026 |
| CM Canadian Imperial Bank of Commerce | FY2026 Q3 · Calendar Q3 2026 | +8.9% | -2.8% | CIBC Q3: Broad growth, resilient credit and expanded AI rollout |
| TD The Toronto-Dominion Bank | FY2026 Q3 · Calendar Q3 2026 | +13.8% | +1.4% | TD emphasizes growth investments alongside disciplined capital management |
| RY Royal Bank of Canada | FY2026 Q3 · Calendar Q3 2026 | +6.2% | -1.3% | RBC reports record Q3 earnings while investing for growth |
| AFRM Affirm Holdings, Inc. | FY2026 Q4 · Calendar Q3 2026 | +1230.3% | +0.3% | Affirm's most profitable quarter shifts focus to product execution |
Latest beats and misses
Who reports nextBeat on EPS
- FPSFY2026 Q4 · September 15, 2026+4.3% EPS+9.5% move
- TCOMFY2026 Q2 · September 15, 2026+22.3% EPS+3.0% move
- KRFY2026 Q2 · September 11, 2026+2.8% EPS+2.7% move
- ADBEFY2026 Q3 · September 10, 2026+0.8% EPS+1.4% move
- ORCLFY2027 Q1 · September 10, 2026+10.3% EPS-1.7% move
- CASYFY2027 Q1 · September 8, 2026+8.7% EPS-14.2% move
Get the SLF recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-08-07T17:16:17.636512+00:00
- FN2 earnings calendar · 2026-09-11T01:23:15.000588+00:00
- Polygon adjusted daily market bars · 2026-09-22T00:40:47.747690+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-22T00:40:47.744963+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.